Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 5;14(1):20699.
doi: 10.1038/s41598-024-71739-y.

IGF-I concentration determines cell fate by converting signaling dynamics as a bifurcation parameter in L6 myoblasts

Affiliations

IGF-I concentration determines cell fate by converting signaling dynamics as a bifurcation parameter in L6 myoblasts

Ryosuke Okino et al. Sci Rep. .

Abstract

Insulin-like growth factor (IGF)-I mediates long-term activities that determine cell fate, including cell proliferation and differentiation. This study aimed to characterize the mechanisms by which IGF-I determines cell fate from the aspect of IGF-I signaling dynamics. In L6 myoblasts, myogenic differentiation proceeded under low IGF-I levels, whereas proliferation was enhanced under high levels. Mathematical and experimental analyses revealed that IGF-I signaling oscillated at low IGF-I levels but remained constant at high levels, suggesting that differences in IGF-I signaling dynamics determine cell fate. We previously reported that differential insulin receptor substrate (IRS)-1 levels generate a driving force for cell competition. Computational simulations and immunofluorescence analyses revealed that asynchronous IRS-1 protein oscillations were synchronized during myogenic processes through cell competition. Disturbances of cell competition impaired signaling synchronization and cell fusion, indicating that synchronization of IGF-I signaling oscillation is critical for myoblast cell fusion to form multinucleate myotubes.

Keywords: Bifurcation analysis; Cell competition; Insulin-like growth factor-I; L6 myoblast; Myogenesis; Signaling dynamics; Signaling oscillation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Effects of IGF-I concentration on IGF-I signaling pathway dynamics and bioactivity expression. (A) L6 myoblasts were incubated in a differentiation medium (DMEM with 2% fetal bovine serum (FBS)) supplemented with either 0 or 100 ng/mL insulin-like growth factor-I (IGF-I). Cell lysates were collected at 0, 1, or 2 days post-differentiation induction for immunoblotting analysis using the specified antibody. (B) L6 myoblasts were cultured in a differentiation medium. Cells were fixed with 4% paraformaldehyde at 0 and 4 days post-differentiation induction and subjected to immunostaining analysis using the MyHC antibody. Scale bar = 50 µm. (C) The fusion index was determined (n = 3). Data are presented as mean ± SEM. *P < 0.05, determined by Student’s t-test. (D) L6 myoblasts were cultured in a differentiation medium (DMEM with 2% FBS) supplemented with 0, 1, 10, or 100 ng/mL IGF-I. Forty-four hours later, [methyl-3H] thymidine was added, and after a 4-h incubation, the amount of [3H] incorporated into DNA was measured as an indicator of proliferation ability (n = 6). Data are presented as mean ± SEM. **P < 0.01, analyzed using one-way ANOVA followed by Tukey’s post hoc test.
Fig. 2
Fig. 2
Mathematical model of the IGF-I signaling pathway. (A) Schematic illustration of the IGF-I signaling pathway model. Insulin receptor substrate-1 (IRS-1) inhibits AP2 function, thereby suppressing internalization of the active IGF-I receptor from the plasma membrane. Downstream signaling pathway activation induces the degradation of IRS-1. In this model, IRS-1 is not a mediator but rather a regulator of the IGF signaling pathway. (B) A mathematical model based on the IGF-I signaling pathway. (C,D) Simulation results of the IGF-I signaling pathway. C: k1 = 0.006. D: k1 = 0.06. (E) L6 myoblasts were serum-starved for 18 h, followed by stimulation with DMEM + 2% FBS containing 1 or 100 ng/mL IGF-I. Cell lysates were prepared from each sample, and the total cell lysate was used for immunoblotting analysis with anti-IRS-1, anti-pAkt, or anti-Akt antibodies. BSA bovine serum albumin, mTORC1 mechanistic target of rapamycin complex 1, PI3K phosphatidylinositol 3-kinase.
Fig. 3
Fig. 3
Synchronization of IGF-I signaling oscillations. (A) Cellular automaton-based algorithm considering cell competition. When the target cell is surrounded by low-level IRS-1 cells, target cells are eliminated, and the empty space is replaced by the proliferation of neighboring cells. (B) Cellular automaton simulation results. The IRS-1 level in each cell is shown as a heatmap, and the dead space is in black. At time 0, each cell had different IRS-1 protein levels because IRS-1 oscillation was not synchronized. Over time, IRS-1 protein levels gradually synchronized between neighboring cells. (C) L6 myoblasts were serum-starved for 18 h, followed by stimulation with 100 ng/mL IGF-I for the indicated time. Afterward, cells were fixed and immunostained with anti-IRS-1 antibody. (D) L6 myoblasts were differentiated into myotubes in a differentiation medium. On days 0, 1, or 2 after induction of differentiation, cells were fixed and immunostained with anti-IRS-1 antibody. The green color shows IRS-1, and the blue color indicates the nuclei stained with Hoechst 33342. Scale bar = 20 µm; applicable to all images in each panel. (E) The diversity index was calculated from the data of photographs immunostained with IRS-1 and shown as a graph (n = 4). Results are presented as mean ± SEM. *P < 0.05. One-way ANOVA and Tukey’s post hoc test were performed for assessment.
Fig. 4
Fig. 4
Synchronization of IRS-1 oscillation is critical for cell fusion. (A) L6 myoblast differentiation was induced in the differentiation medium containing Dimethyl sulfoxide (DMSO) or Z-VAD-FMK. At 0 or 4 days after induction of differentiation, cells were fixed and immunostained with an anti-IRS-1 antibody. The green color shows IRS-1, and the blue color indicates the nuclei stained with Hoechst 33342. Scale bar = 50 µm; applicable to all images in each panel. The diversity index was calculated and shown in the graph (n = 4). Results are presented as mean ± SEM. *P < 0.05. One-way ANOVA and Tukey’s post hoc test were performed for assessment. (B) L6 myoblasts were differentiated in the differentiation medium for 4 days. Cells were fixed and immunostained with an anti-MyHC antibody. Scale bar = 20. The fusion index was calculated and shown in the graphs (n = 3). Results are presented as mean ± SEM. *P < 0.05. Student’s t-test was performed for assessment. (C) L6 myoblasts were differentiated in the differentiation medium for 3 days. Myomaker mRNA levels in L6 myoblasts were measured via qPCR (n = 3). Results are presented as mean ± SEM. *P < 0.05. One-way ANOVA and Tukey’s post hoc test were performed for assessment. (D) L6 myoblasts were directly differentiated by exchanging the culture medium from DMEM + 10% FBS to DMEM + 2% FBS (normal). L6 myoblasts were serum-starved for 1 day, followed by differentiation induction in DMEM + 2% FBS. Total cell lysates were prepared for immunoblotting analysis using the indicated antibodies.

Similar articles

References

    1. Nakae, J., Kido, Y. & Accili, D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev.22, 818–835. 10.1210/EDRV.22.6.0452 (2001). 10.1210/EDRV.22.6.0452 - DOI - PubMed
    1. Fukushima, T. et al. Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation. J. Biol. Chem.287, 29713–29721. 10.1074/jbc.M112.393074 (2012). 10.1074/jbc.M112.393074 - DOI - PMC - PubMed
    1. Dumont, N. A., Bentzinger, C. F., Sincennes, M. C. & Rudnicki, M. A. Satellite cells and skeletal muscle regeneration. Compr. Physiol.5, 1027–1059. 10.1002/CPHY.C140068 (2015). 10.1002/CPHY.C140068 - DOI - PubMed
    1. Clemmons, D. R. Role of IGF-I in skeletal muscle mass maintenance. Trends Endocrinol. Metab.20, 349–356. 10.1016/J.TEM.2009.04.002 (2009). 10.1016/J.TEM.2009.04.002 - DOI - PubMed
    1. Barton-Davis, E. R., Shoturma, D. I. & Sweeney, H. L. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol. Scand.167, 301–305. 10.1046/J.1365-201X.1999.00618.X (1999). 10.1046/J.1365-201X.1999.00618.X - DOI - PubMed

Substances

LinkOut - more resources